Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:betrixaban
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
B01AF11
|
| gptkbp:CASNumber |
330942-05-7
|
| gptkbp:drugClass |
gptkb:anticoagulant
factor Xa inhibitor |
| gptkbp:eliminationHalfLife |
19-27 hours
|
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bevyxxa
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Portola_Pharmaceuticals
|
| gptkbp:pregnancyCategory |
N
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:betrixaban
|
| gptkbp:usedFor |
prevention of venous thromboembolism
|
| gptkbp:bfsParent |
gptkb:betrixaban
|
| gptkbp:bfsLayer |
7
|